Terms: = Lung cancer AND TFG, TF6, 10342, ENSG00000114354, Q92734 AND Treatment
11 results:
1. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
Tapia-Galisteo A; Sánchez-Rodríguez I; Narbona J; Iglesias-Hernández P; Aragón-García S; Jiménez-Reinoso A; Compte M; Khan S; Tsuda T; Chames P; Lacadena J; Álvarez-Vallina L; Sanz L
Oncoimmunology; 2024; 13(1):2338558. PubMed ID: 38623463
[TBL] [Abstract] [Full Text] [Related]
2. ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via
Chuang TP; Lai WY; Gabre JL; Lind DE; Umapathy G; Bokhari AA; Bergman B; Kristenson L; Thorén FB; Le A; Doebele RC; Van den Eynden J; Palmer RH; Hallberg B
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2216479120. PubMed ID: 36791109
[TBL] [Abstract] [Full Text] [Related]
3. tfg-β Nuclear Staining as a Potential Relapse Risk Factor in Early-Stage Non-Small-Cell lung cancer.
Cárdenas-Quesada N; Díaz-Beltrán L; Rosa-Garrido C; Márquez-Lobo B; Sabio-González A; Luque-Barona RJ; Núñez MI; Sánchez-Rovira P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430262
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy.
Wachter F; Al-Ibraheemi A; Trissal MC; Hollowell M; DuBois SG; Collins NB; Church AJ; Janeway KA
Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814185
[TBL] [Abstract] [Full Text] [Related]
5. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.
Feng T; Chen Z; Gu J; Wang Y; Zhang J; Min L
Lung Cancer; 2019 Nov; 137():19-22. PubMed ID: 31521978
[TBL] [Abstract] [Full Text] [Related]
6. Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease.
Shimura K; Shibata H; Mizuno Y; Amano N; Hoshino K; Kuroda T; Kameyama K; Matsuse M; Mitsutake N; Sugino K; Yoshimura Noh J; Hasegawa T; Ishii T
Horm Res Paediatr; 2019; 91(3):210-215. PubMed ID: 30092570
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics and Outcome of ROS1-Positive Non-Small Cell lung cancer Patients in Routine Clinical Practice.
Park S; Ahn BC; Lim SW; Sun JM; Kim HR; Hong MH; Lee SH; Ahn JS; Park K; Choi Y; Cho BC; Ahn MJ
J Thorac Oncol; 2018 Sep; 13(9):1373-1382. PubMed ID: 29883837
[TBL] [Abstract] [Full Text] [Related]
8. Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.
Tiseo M; Gelsomino F; Bartolotti M; Bordi P; Bersanelli M; Rossi G; Ardizzoni A
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1677-87. PubMed ID: 22050016
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical study on effects of tiepi fengdou granule/capsule combined with chemotherapy and/or radiotherapy in treating lung cancer with Qi-Yin asthenia syndrome].
Chen XP; Zhang YP; Zhu XR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):394-7. PubMed ID: 16883902
[TBL] [Abstract] [Full Text] [Related]
10. Risk of long-term complications after tfg-beta1-guided very-high-dose thoracic radiotherapy.
Anscher MS; Marks LB; Shafman TD; Clough R; Huang H; Tisch A; Munley M; Herndon JE; Garst J; Crawford J; Jirtle RL
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):988-95. PubMed ID: 12829134
[TBL] [Abstract] [Full Text] [Related]
11. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
Rachwal WJ; Bongiorno PF; Orringer MB; Whyte RI; Ethier SP; Beer DG
Br J Cancer; 1995 Jul; 72(1):56-64. PubMed ID: 7599067
[TBL] [Abstract] [Full Text] [Related]
